Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases

Autor: Dudink, EAMP, Weijs, B, Luermans, JGLM, Peeters, FECM, Altintas, S, Vernooy, K, Pison, LAFG, Haest, RJ, Kragten, JA, Kietselaer, BLJH, Wildberger, JE, Crijns, HJGM

Publikováno v: J Atr Fibrillation

BACKGROUND: Previous research showed a significant difference in the presence of subclinical coronary artery disease (CAD) on cardiac CT angiography (CTA) between patients with idiopathic paroxysmal atrial fibrillation (iAF) versus a matched sinus rh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e74229331e97985a49bfcf0cc1dcb5b
https://europepmc.org/articles/PMC8691298/

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions.

Autor: Chua W; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Cardoso VR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; MRC Health Data Research UK (HDR), Midlands Site, London, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Guasch E; Hospital Clinic de Barcelona, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain., Sinner MF; Department of Medicine I, University Hospital, LMU, Munich, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site: Munich Heart Alliance, Munich, Germany., Al-Taie C; University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, UKE Martinistrasse 52, 20246, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg/Kiel/Lübeck, Hamburg, Germany.; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Brady P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Casadei B; University of Oxford, Oxford, UK., Crijns HJGM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Dudink EAMP; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Hatem SN; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France., Kääb S; Department of Medicine I, University Hospital, LMU, Munich, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site: Munich Heart Alliance, Munich, Germany., Kastner P; Roche Diagnostics GmbH, Penzberg, Germany., Mont L; Hospital Clinic de Barcelona, Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Barcelona, Spain., Nehaj F; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Purmah Y; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Reyat JS; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Schotten U; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Sommerfeld LC; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, UKE Martinistrasse 52, 20246, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg/Kiel/Lübeck, Hamburg, Germany.; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zeemering S; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., Ziegler A; Roche Diagnostics International AG, Rotkreuz, Switzerland., Gkoutos GV; MRC Health Data Research UK (HDR), Midlands Site, London, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Kirchhof P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg/Kiel/Lübeck, Hamburg, Germany.; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fabritz L; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. L.Fabritz@uke.de.; University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, UKE Martinistrasse 52, 20246, Hamburg, Germany. L.Fabritz@uke.de.; German Centre for Cardiovascular Research (DZHK), Partner Site: Hamburg/Kiel/Lübeck, Hamburg, Germany. L.Fabritz@uke.de.; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. L.Fabritz@uke.de.

Publikováno v: Scientific reports [Sci Rep] 2023 Oct 05; Vol. 13 (1), pp. 16743. Date of Electronic Publication: 2023 Oct 05.

Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study.

Autor: Meems LMG; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Artola Arita V; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Velt M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Dudink EAMP; Maastricht University Medical Center+ and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands., Crijns HJGM; Maastricht University Medical Center+ and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands., Van Gelder IC; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Rienstra M; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Publikováno v: International journal of cardiology. Heart & vasculature [Int J Cardiol Heart Vasc] 2022 Mar 08; Vol. 39, pp. 100987. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).

Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation.

Autor: Pluymaekers NAHA; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands. nikki.pluymaekers@mumc.nl., Dudink EAMP; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Weijs B; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Vernooy K; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands., Hartgerink DEJ; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Jacobs JS; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Erküner Ö; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Marcks NGHM; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., van Cauteren YJM; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Dinh T; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Ter Bekke RMA; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Sels JEMW; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Intensive Care Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Delnoij TSR; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Intensive Care Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Geyik Z; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Intensive Care Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Driessen RGH; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Intensive Care Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Linz DK; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands., den Uijl DW; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Crijns HJGM; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Luermans JGLM; Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2021 May; Vol. 29 (5), pp. 255-261. Date of Electronic Publication: 2021 Jan 06.

Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?

Autor: Peeters FECM; Department of Cardiology and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Dudink EAMP; Department of Cardiology and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Weijs B; Department of Cardiology and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Fabritz L; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Chua W; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Kietselaer BLJH; Department of Cardiology and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Wildberger JE; Department of Radiology and Nuclear Medicine and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Meex SJR; Department of Clinical Chemistry and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Kirchhof P; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom., Crijns HJGM; Department of Cardiology and CARIM, Maastricht University Medical Center+, School for Cardiovascular Diseases, Maastricht, Netherlands., Schurgers LJ; Department of Biochemistry and CARIM, Maastricht University, School for Cardiovascular Diseases, Maastricht, Netherlands.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2020 Jul 10; Vol. 8, pp. 604. Date of Electronic Publication: 2020 Jul 10 (Print Publication: 2020).